October 13, 2011
The Ministry of Health, Labor and Welfare (MHLW; Korosho ) announced on October 5 the NDA (new drug application) review report on the additional indication of inoperable or relapsed breast cancer for Chugai Pharmaceutical’s Avastin (bevacizumab) approved on September 26...read more